Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas(University of California, Los Angeles), Reinhard Dummer(University Hospital of Zurich), Igor Puzanov(Roswell Park Comprehensive Cancer Center), Ari M. Vanderwalde(Campbell Clinic), Robert H.I. Andtbacka(University of Utah), Olivier Michielin(University Hospital of Lausanne), Anthony J. Olszanski(Fox Chase Cancer Center), Josep Malvehy(Hospital Clínic de Barcelona), Jonathan Cebon(La Trobe University), Eugenio Fernández(Hôpital Beau-Séjour), John M. Kirkwood(UPMC Hillman Cancer Center), Thomas F. Gajewski(University of Chicago), Lisa Chen(Amgen (United States)), Kevin Gorski(Amgen (United States)), Abraham Anderson(Amgen (United States)), Scott J. Diede(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael E. Lassman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jennifer Gansert(Amgen (United States)), F. Stephen Hodi(Dana-Farber Cancer Institute), Georgina V. Long(The University of Sydney)
Cited by 1,475Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis